Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
Ultima descărcare din IBN: 2024-06-11 17:06 |
![]() COREŢCHI, Ianoş, PESHKOVA, Maria, NOI, Autori, GALEA-ABDUȘA, Daniela, ULINICI, Mariana, VOROJBIT, Valentina, GROPPA, Stanislav, TODIRAŞ, Mihail. EVs vs. EVs: MSCs and Tregs as a source of invisible possibilities. In: Journal of Molecular Medicine, 2023, nr. 1-2(101), pp. 51-63. ISSN 0946-2716. DOI: https://doi.org/10.1007/s00109-022-02276-2 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Journal of Molecular Medicine | |
Numărul 1-2(101) / 2023 / ISSN 0946-2716 /ISSNe 1432-1440 | |
|
|
DOI:https://doi.org/10.1007/s00109-022-02276-2 | |
Pag. 51-63 | |
![]() |
|
Rezumat | |
Extracellular vesicles (EVs) are produced by various cells and exist in most biological fluids. They play an important role in cell–cell signaling, immune response, and tumor metastasis, and also have theranostic potential. They deliver many functional biomolecules, including DNA, microRNAs (miRNA), messenger RNA (mRNA), long non-coding RNA (lncRNA), lipids, and proteins, thus affecting different physiological processes in target cells. Decreased immunogenicity compared to liposomes or viral vectors and the ability to cross through physiological barriers such as the blood–brain barrier make them an attractive and innovative option as diagnostic biomarkers and therapeutic carriers. Here, we highlighted two types of cells that can produce functional EVs, namely, mesenchymal stem/stromal cells (MSCs) and regulatory T cells (Tregs), discussing MSC/Treg-derived EV-based therapies for some specific diseases including acute respiratory distress syndrome (ARDS), autoimmune diseases, and cancer. |
|
Cuvinte-cheie Extracellular vesicles, Mesenchymal stem, Regulatory T cells, Stromal cells |
|
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <identifier identifierType='DOI'>10.1007/s00109-022-02276-2</identifier> <creators> <creator> <creatorName>Coreţchi, I.G.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Peshkova, M.</creatorName> <affiliation>Первый Московский государственный медицинский университет им. И.М. Сеченова, РАМН, Rusia</affiliation> </creator> <creator> <creatorName>Noi, A.</creatorName> </creator> <creator> <creatorName>Galea-Abdușa, D.I.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Ulinici, M.G.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Vorojbit, V.U.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Groppa, S.A.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Todiraş, M.P.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='en'>EVs vs. EVs: MSCs and Tregs as a source of invisible possibilities</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2023</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>0946-2716</relatedIdentifier> <subjects> <subject>Extracellular vesicles</subject> <subject>Mesenchymal stem</subject> <subject>Regulatory T cells</subject> <subject>Stromal cells</subject> </subjects> <dates> <date dateType='Issued'>2023-02-01</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'><p>Extracellular vesicles (EVs) are produced by various cells and exist in most biological fluids. They play an important role in cell–cell signaling, immune response, and tumor metastasis, and also have theranostic potential. They deliver many functional biomolecules, including DNA, microRNAs (miRNA), messenger RNA (mRNA), long non-coding RNA (lncRNA), lipids, and proteins, thus affecting different physiological processes in target cells. Decreased immunogenicity compared to liposomes or viral vectors and the ability to cross through physiological barriers such as the blood–brain barrier make them an attractive and innovative option as diagnostic biomarkers and therapeutic carriers. Here, we highlighted two types of cells that can produce functional EVs, namely, mesenchymal stem/stromal cells (MSCs) and regulatory T cells (Tregs), discussing MSC/Treg-derived EV-based therapies for some specific diseases including acute respiratory distress syndrome (ARDS), autoimmune diseases, and cancer.</p></description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>